Cite
HARVARD Citation
Jones, S. et al. (2022). Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet. 399 (10322), pp. 359-371. [Online].